Drugs / Mineralized Plasmatic Matrix
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07239193 Comparator | Dec 2025 → Jul 2026 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mineralized Plasmatic Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07239193 ↗ |
| Known as | MPM | “The second method uses a Mineralized Plasmatic Matrix (MPM), a combination of a xenograft bone substitute mixed with Platelet-Rich Plasma (PRP), which represents a widely used...” NCT07239193 ↗ |
| Modality | Other / unclassified | “A xenogenic bone substitute is mixed with autologous platelet-rich plasma to form a mineralized plasmatic matrix, which serves as a control graft for ridge preservation after...” NCT07239193 ↗ |